search
Back to results

A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury

Primary Purpose

Blindness

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
BrainPort V200 Device
Sponsored by
Wicab
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Blindness focused on measuring Assistive technology, Non-surgical visual prosthetic, sensory substitution, BrainPort, Blindness, Assistive device

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. A minimum age of 18 years at enrollment.
  2. A documented vision diagnosis of light perception or worse bilaterally.
  3. Blinded by traumatic injury (i.e., ocular or cortical trauma).
  4. Minimum post 12 months diagnosis of blindness.
  5. Previous completion of conventional rehabilitation such as orientation and mobility training with a cane or guide dog.
  6. Ability to read (or have read to them) and understand study documents and procedures.
  7. Ability to provide valid feedback regarding use of the BrainPort device.
  8. Access to an accessible computer and internet connection.
  9. Willing and able to complete all questionnaires, telephone conferences, device training, and study procedures required by the protocol, after completing an orientation period with the device.
  10. Ability to operate a tablet computer.

Exclusion Criteria:

  1. Current oral health problems determined by the participant's medical history and an examination of the oral cavity performed by study personnel.
  2. History of injury to the tongue resulting in impaired sensation of use of the tongue.
  3. Visible open lesions, cold sores, abrasions, blisters, or rash on the tongue, numbness or lack of feeling of the tongue.
  4. Piercings on the tongue.
  5. Recent or planned oral surgery and/or dental work in the past three months (does not include routine dental health exams/cleanings).
  6. Known neuropathies of the tongue or tactile system.
  7. History of seizures or epilepsy.
  8. If female, pregnant or breast feeding by self-report. Women of child bearing potential must agree to use appropriate birth control to prevent pregnancy for the duration of the study.
  9. People with implanted medical devices (i.e., pacemaker, deep brain stimulator, cochlear implant).
  10. Any hearing impairments which prevents hearing the device announcements.
  11. Any cognitive disabilities (such as Alzheimer's disease), as determined by medical history and/or the Telephone Inventory Cognitive Screening (TICS).
  12. Participation in any other clinical trial or research while my confound results in either study.
  13. Known allergy to nickel, gold, or any component of stainless steel.
  14. Any medical condition that would interfere with performance on the assessments.
  15. The Site Principal Investigator does not deem the candidate to be suitable for the study for other reasons not listed above.

Sites / Locations

  • The Chicago Lighthouse for People Who Are Blind or Visually Impaired
  • Lighthouse Guild
  • Wicab, Inc.

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

BrainPort V200 Device

Arm Description

Single Arm

Outcomes

Primary Outcome Measures

To assess the safety of electrical stimulation on the tongue (to demonstrate no occurrence of a clinically significant device-related adverse event)
The primary safety objective is to demonstrate no occurrence of a clinically significant device-related adverse event.
To assess the efficacy of the BrainPort device as measured by an object recognition task (to demonstrate at least 35% of subjects achieve a success rate in object recognition exceeding that expected by chance alone)
The primary efficacy objective is to demonstrate that at least 35% of subjects achieve a success rate in object recognition exceeding that expected by chance alone.

Secondary Outcome Measures

Full Information

First Posted
March 2, 2015
Last Updated
March 1, 2016
Sponsor
Wicab
Collaborators
The Chicago Lighthouse, Lighthouse Guild
search

1. Study Identification

Unique Protocol Identification Number
NCT02393118
Brief Title
A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury
Official Title
Safety and Efficacy of the BrainPort V200 Device in Individuals Blinded by Traumatic Injury
Study Type
Interventional

2. Study Status

Record Verification Date
March 2016
Overall Recruitment Status
Unknown status
Study Start Date
September 2014 (undefined)
Primary Completion Date
September 2016 (Anticipated)
Study Completion Date
September 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Wicab
Collaborators
The Chicago Lighthouse, Lighthouse Guild

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The BrainPort V200 Device is a wearable, non-surgical, prosthetic device intended for people who are profoundly blind. The BrainPort V200 translates images captured by a digital camera into electro-tactile stimulation presented on the user's tongue to perceive shape, size, location, and motion of objects within the environment. The purpose of this study is to evaluate the safety and functional performance of the BrainPort V200 device in individuals who have been medically documented as blind, light perception or worse, due to a traumatic injury (cortical or ocular).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Blindness
Keywords
Assistive technology, Non-surgical visual prosthetic, sensory substitution, BrainPort, Blindness, Assistive device

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
BrainPort V200 Device
Arm Type
Experimental
Arm Description
Single Arm
Intervention Type
Device
Intervention Name(s)
BrainPort V200 Device
Intervention Description
Training in clinic on use of the device for 2-3 days (10 hours) followed by in-home use for a minimum of 300 minutes per month over 12 months.
Primary Outcome Measure Information:
Title
To assess the safety of electrical stimulation on the tongue (to demonstrate no occurrence of a clinically significant device-related adverse event)
Description
The primary safety objective is to demonstrate no occurrence of a clinically significant device-related adverse event.
Time Frame
12 months
Title
To assess the efficacy of the BrainPort device as measured by an object recognition task (to demonstrate at least 35% of subjects achieve a success rate in object recognition exceeding that expected by chance alone)
Description
The primary efficacy objective is to demonstrate that at least 35% of subjects achieve a success rate in object recognition exceeding that expected by chance alone.
Time Frame
12 months
Other Pre-specified Outcome Measures:
Title
Text identification task
Description
Words or sequence of numbers will be presented on flashcards and a mobile tablet, subjects will be asked to verbally identify which word or number is presented.
Time Frame
12 months
Title
Navigation task
Description
Subjects will be required to identify key characteristics of a room, such as the number of windows and doorways and complete navigation tasks such as following a line, avoiding obstacles, and walking through a doorway without touching any walls.
Time Frame
12 months
Title
Change in the effect of assistive technology on perceived quality of life after using the device for one year as measured by the Psychosocial Impact of Assistive Devices Scale (PIADS).
Time Frame
Baseline, 12 months after device training.
Title
Change in self-efficacy after using the device for one year as measured by the General Self-Efficacy Scale (GSES)
Time Frame
Basline, 12 months after device training.
Title
Change in perceived general pain after using the device for one year as measured by the Universal Pain Assessment Tool
Time Frame
Baseline,12 months after device training
Title
Change in satisfaction of the device after using the device for one year, as measured by the Device Satisfaction Survey
Time Frame
One month after start of home use, 12 months after device training
Title
Optional focus group to assess year long experience with the device.
Time Frame
12 months after device training

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: A minimum age of 18 years at enrollment. A documented vision diagnosis of light perception or worse bilaterally. Blinded by traumatic injury (i.e., ocular or cortical trauma). Minimum post 12 months diagnosis of blindness. Previous completion of conventional rehabilitation such as orientation and mobility training with a cane or guide dog. Ability to read (or have read to them) and understand study documents and procedures. Ability to provide valid feedback regarding use of the BrainPort device. Access to an accessible computer and internet connection. Willing and able to complete all questionnaires, telephone conferences, device training, and study procedures required by the protocol, after completing an orientation period with the device. Ability to operate a tablet computer. Exclusion Criteria: Current oral health problems determined by the participant's medical history and an examination of the oral cavity performed by study personnel. History of injury to the tongue resulting in impaired sensation of use of the tongue. Visible open lesions, cold sores, abrasions, blisters, or rash on the tongue, numbness or lack of feeling of the tongue. Piercings on the tongue. Recent or planned oral surgery and/or dental work in the past three months (does not include routine dental health exams/cleanings). Known neuropathies of the tongue or tactile system. History of seizures or epilepsy. If female, pregnant or breast feeding by self-report. Women of child bearing potential must agree to use appropriate birth control to prevent pregnancy for the duration of the study. People with implanted medical devices (i.e., pacemaker, deep brain stimulator, cochlear implant). Any hearing impairments which prevents hearing the device announcements. Any cognitive disabilities (such as Alzheimer's disease), as determined by medical history and/or the Telephone Inventory Cognitive Screening (TICS). Participation in any other clinical trial or research while my confound results in either study. Known allergy to nickel, gold, or any component of stainless steel. Any medical condition that would interfere with performance on the assessments. The Site Principal Investigator does not deem the candidate to be suitable for the study for other reasons not listed above.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Patricia Grant, M.S.
Organizational Affiliation
Wicab, Inc.
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Chicago Lighthouse for People Who Are Blind or Visually Impaired
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60608
Country
United States
Facility Name
Lighthouse Guild
City
New York
State/Province
New York
ZIP/Postal Code
10022
Country
United States
Facility Name
Wicab, Inc.
City
Middleton
State/Province
Wisconsin
ZIP/Postal Code
53562
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
30169354
Citation
Grant P, Maeng M, Arango T, Hogle R, Szlyk J, Seiple W. Performance of Real-world Functional Tasks Using an Updated Oral Electronic Vision Device in Persons Blinded by Trauma. Optom Vis Sci. 2018 Sep;95(9):766-773. doi: 10.1097/OPX.0000000000001273.
Results Reference
derived

Learn more about this trial

A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury

We'll reach out to this number within 24 hrs